Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 87441-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 87441-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

87441-013-01 Label (8744101301)

87441-013-01 Label (8744101301)
Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets. The label includes the NDC 87441-013-01 and states it is Rx only. It provides storage instructions at 20° to 25°C, pharmacist dispensing guidance, and repackaging and distribution information for Unit Dose Solutions, Inc. and Tuckahoe Enterprises, LLC.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing the cumulative incidence percentage over time in years between Atorvastatin and Placebo groups. The graph shows two lines: a solid line for Atorvastatin and a dotted line for Placebo, indicating lower cumulative incidence in the Atorvastatin group. A hazard ratio and p-value are noted below the chart.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin groups. The x-axis represents time in years (up to 5 years), and the y-axis shows cumulative hazard as a percentage. The graph illustrates lower cumulative hazard in the atorvastatin group versus placebo, with a hazard ratio (HR) of 0.63 and a p-value of 0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time in years to first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. Two lines show event rates for the two doses, with associated hazard ratio and p-value displayed.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, depicted with calcium ions (Ca2+) and associated molecular groups. The diagram shows the molecular framework relevant to the active ingredient atorvastatin calcium used in the 40 mg oral film-coated tablets by Unit Dose Solutions, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.